Quanterix Inc (QTRX) - Rasio Kapitalisasi Pasar marang Nilai Buku

Quanterix (QTRX) - logo korporat

Production capacities for protein analysis systems are operating at full capacity, and equipment has been upgraded. Quanterix Corporation (QTRX) relies on stable agreements with pharmaceutical corporations, which minimizes cyclical impact, and the current figure stands at 0.62. The price chart for Quanterix Corporation (QTRX) clearly demonstrates the asset's dynamics. However, export restrictions and chip shortages are hindering expansion into Asia and slowing the production of complex instruments.

Quanterix Inc (QTRX) - Kapitalisasi Pasar marang Nilai Buku saka 04.07.2022 nganti 30.10.2026

Rincian metrik lan analitis perusahaan Quanterix Corp. (QTRX)

- rega saham lan konsensus proyeksi valuasi:
Kutipan saham Quanterix Corporation|QTRX - Prakiraan gabungan firma investasi
- indikator kapitalisasi pasar:
Kapitalisasi pasar Quanterix Corp|QTRX - Nilai Bisnis
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Quanterix|QTRX - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku quanterix.com|QTRX - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Quanterix Corporation|QTRX - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Quanterix Corp|QTRX - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Quanterix Corp|QTRX - Utang jangka dawa|Utang jangka cendhak perusahaan Quanterix|Indikator likuiditas cepet quanterix.com
- indikator bathi lan kelipatan valuasi:
QTRX - Bathi sawise mbayar pajeg
Ringkesan analisis perusahaan:Quanterix Corporation
Barang unggulan Quanterix Corp

This indicator expresses the ratio of the current market value of Quanterix Corporation (QTRX) to its total equity, measuring the degree of asset premium or discount relative to their book value. In the context of full capacity utilization for diagnostic system production and the modernization of the machine tool fleet, changes in the revaluation level of balance sheet capital reflect market expectations regarding the future efficiency of the company's high-tech infrastructure.

Analisis perusahaan pesaing

ABT (Abbott Laboratories) - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi marang Nilai Buku TMO|GEHC (GE HealthCare Technologies) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku MTD (Mettler-Toledo)|Rasio Kapitalisasi Pasar marang Nilai Buku WAT|Kapitalisasi Pasar marang Nilai Buku Bio-Techne Inc.|Rasio Kapitalisasi Pasar marang Nilai Buku BRKR (Bruker Corporation)|Rasio Kapitalisasi Pasar marang Nilai Buku azenta.com AZTA|Varex Imaging Corporation - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Ekuitas Semler Scientific Inc (SMLR)|Butterfly iQ (BFLY) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku MLAB|Rasio Nilai Pasar marang Nilai Buku Quantum-Si|Koefisien Nilai Pasar marang Nilai Buku nanox.vision NNOX|Rasio Nilai Pasar marang Nilai Buku 908 Devices (MASS)|Kapitalisasi Pasar marang Nilai Buku capsovision.com|MaxCyte, Inc - Rasio Kapitalisasi marang Aset Bersih|Multiplikator Kapitalisasi Pasar marang Nilai Buku RPID (Rapid Micro Biosystems Inc.)|Seer, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku hyperfine.io HYPR|FONR: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Daxor|Rasio Kapitalisasi marang Aset Bersih MDAI|VIVS: Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Aclarion (ACON)|Rasio Kapitalisasi marang Aset Bersih akoyabio.com AKYA|Rasio Kapitalisasi Pasar marang Nilai Buku THMO (ThermoGenesis Holdings)|Talis Biomedical Corp. (TLIS) - Koefisien Nilai Pasar marang Nilai Buku|T2 Biosystems, Inc - Rasio Kapitalisasi Pasar marang Nilai Buku